Literature DB >> 8580276

The effect of treatment on lymphokine-secreting cells in the intestinal mucosa of children with Crohn's disease.

E J Breese1, C A Michie, S W Nicholls, C B Williams, P Domizio, J A Walker-Smith, T T MacDonald.   

Abstract

BACKGROUND: Recent studies have shown both interleukin 2 (IL-2) and interferon gamma (IFN) to be elevated in patients with active Crohn's disease compared to ulcerative colitis or non-inflammatory bowel disease controls. However the effect of treatment on these lymphokines has not been studied. PATIENTS AND METHODS: Using a reverse haemolytic plaque assay the percentage of lymphokine-secreting cells was determined in the intestinal mucosa of children with Crohn's disease before and after 8 weeks of treatment with either enteral nutrition, cyclosporin or steroids.
RESULTS: Before treatment, a high percentage of cells isolated from mucosal biopsies secreted IL-2 or interferon-gamma. Eight weeks' treatment with the immunosuppressive agents cyclosporin, or with corticosteroids, produced a significant reduction in the percentage of IL-2 secreting cells, although only for the former was there also a reduction in interferon-gamma secreting cells. Enteral nutrition however, produced a reduction in lymphokine-secreting cells equivalent to cyclosporin and produced the best histological and clinical improvement.
CONCLUSION: Enteral nutrition and cyclosporin can down-regulate lymphokine secretion in the gut in Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8580276     DOI: 10.1111/j.1365-2036.1995.tb00419.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  16 in total

Review 1.  Chronic inflammatory bowel disease in children: a complex problem in management.

Authors:  J A Walker-Smith
Journal:  Postgrad Med J       Date:  2000-08       Impact factor: 2.401

Review 2.  An update of the role of nutritional therapy in the management of Crohn's disease.

Authors:  Moftah H Alhagamhmad; Andrew S Day; Daniel A Lemberg; Steven T Leach
Journal:  J Gastroenterol       Date:  2012-06-15       Impact factor: 7.527

3.  Polymeric formula has direct anti-inflammatory effects on enterocytes in an in vitro model of intestinal inflammation.

Authors:  Naomi S H de Jong; Steven T Leach; Andrew S Day
Journal:  Dig Dis Sci       Date:  2007-04-04       Impact factor: 3.199

4.  Acute duodenal Crohn's disease successfully managed with low-speed elemental diet infusion via nasogastric tube: a case report.

Authors:  Takayuki Yamamoto; Maki Nakahigashi; Satoru Umegae; Tatsushi Kitagawa; Koichi Matsumoto
Journal:  World J Gastroenterol       Date:  2006-01-28       Impact factor: 5.742

5.  Management of growth failure in Crohn's disease.

Authors:  J A Walker-Smith
Journal:  Arch Dis Child       Date:  1996-10       Impact factor: 3.791

6.  Specialized enteral nutrition therapy in Crohn's disease patients on maintenance infliximab therapy: a meta-analysis.

Authors:  Douglas L Nguyen; Lena B Palmer; Emily T Nguyen; Stephen A McClave; Robert G Martindale; Matthew L Bechtold
Journal:  Therap Adv Gastroenterol       Date:  2015-07       Impact factor: 4.409

Review 7.  Histological healing in inflammatory bowel disease: a still unfulfilled promise.

Authors:  Vincenzo Villanacci; Elisabetta Antonelli; Karel Geboes; Giovanni Casella; Gabrio Bassotti
Journal:  World J Gastroenterol       Date:  2013-02-21       Impact factor: 5.742

Review 8.  Systematic review with meta-analysis: enteral nutrition therapy for the induction of remission in paediatric Crohn's disease.

Authors:  A Swaminath; A Feathers; A N Ananthakrishnan; L Falzon; S Li Ferry
Journal:  Aliment Pharmacol Ther       Date:  2017-08-16       Impact factor: 8.171

9.  Risk factors for relapse and surgery rate in children with Crohn's disease.

Authors:  Iva Hojsak; Ana Močić Pavić; Zrinjka Mišak; Sanja Kolaček
Journal:  Eur J Pediatr       Date:  2013-12-06       Impact factor: 3.183

10.  Preoperative exclusive enteral nutrition reduces the postoperative septic complications of fistulizing Crohn's disease.

Authors:  G Li; J Ren; G Wang; D Hu; G Gu; S Liu; H Ren; X Wu; J Li
Journal:  Eur J Clin Nutr       Date:  2014-02-19       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.